Small-Cap Catalyst Pharmaceuticals Is Among Market's Best Price Performers
Small-cap biotech Catalyst Pharmaceuticals (NASDAQ:CPRX) has been outperforming the broader market, amid recent earnings and revenue acceleration.
Source: valuewalk.com
Stay updated with breaking news from While Catalyst Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Small-cap biotech Catalyst Pharmaceuticals (NASDAQ:CPRX) has been outperforming the broader market, amid recent earnings and revenue acceleration.
Their low price tags belie their massive long-term potential.